Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist
- PMID: 27490046
- DOI: 10.1016/j.fertnstert.2016.07.1068
Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist
Abstract
Objective: To identify the risk factors for suboptimal response to GnRH agonist (GnRH-a) trigger and evaluate the effect of hCG on the outcome of patients with suboptimal response to GnRH-a.
Design: A retrospective data analysis.
Setting: A tertiary-care academic medical center.
Patient(s): A total of 8,092 women undergoing 8,970 IVF/intracytoplasmic sperm injection (ICSI) treatment cycles.
Intervention(s): All women underwent hMG + medroxyprogesterone acetate (MPA)/P treatment cycles during IVF/ICSI, which were triggered using a GnRH-a alone or in combination with hCG (1,000, 2,000, or 5,000 IU). Viable embryos were cryopreserved for later transfer.
Main outcome measure(s): The rates of oocyte retrieval, mature oocytes, fertilization, and the number of oocytes retrieved, mature oocytes, and embryos frozen.
Result(s): In total, 2.71% (243/8,970) of patients exhibited a suboptimal response to GnRH-a. The suboptimal responders (LH ≤15 mIU/mL) had a significantly lower oocyte retrieval rate (48.16% vs. 68.26%), fewer mature oocytes (4.10 vs. 8.29), and fewer frozen embryos (2.32 vs. 3.54) than the appropriate responders. Basal LH levels served as the single most valuable marker for differentiating suboptimal responders with the areas under the receiver operating curve of 0.805. Administering dual trigger (GnRH-a and hCG 1,000, 2,000, 5,000 IU) significantly increased oocyte retrieval rates (60.04% vs. 48.16%; 68.13% vs. 48.16%; and 65.76% vs. 48.16%, respectively) in patients with a suboptimal response.
Conclusion(s): Basal LH level was useful predictor of the suboptimal response to GnRH-a trigger. Administrating dual trigger including 1,000 IU hCG for final oocyte maturation could improve the oocytes retrieval rate of GnRH-a suboptimal responder.
Keywords: GnRH-a; IVF; Infertility; dual trigger; hCG.
Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.Fertil Steril. 2016 Oct;106(5):1093-1100.e3. doi: 10.1016/j.fertnstert.2016.06.013. Epub 2016 Jun 21. Fertil Steril. 2016. PMID: 27341988
-
Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.Fertil Steril. 2014 Aug;102(2):405-9. doi: 10.1016/j.fertnstert.2014.04.028. Epub 2014 May 17. Fertil Steril. 2014. PMID: 24842671
-
Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.Fertil Steril. 2013 Nov;100(5):1296-302. doi: 10.1016/j.fertnstert.2013.07.1976. Epub 2013 Aug 28. Fertil Steril. 2013. PMID: 23993928
-
Can Ratios Between Prognostic Factors Predict the Clinical Pregnancy Rate in an IVF/ICSI Program with a GnRH Agonist-FSH/hMG Protocol? An Assessment of 2421 Embryo Transfers, and a Review of the Literature.Reprod Sci. 2021 Feb;28(2):495-509. doi: 10.1007/s43032-020-00307-2. Epub 2020 Sep 4. Reprod Sci. 2021. PMID: 32886340 Review.
-
Triggering oocyte maturation in in vitro fertilization treatment in healthy responders: a systematic review and network meta-analysis.Fertil Steril. 2025 May;123(5):812-826. doi: 10.1016/j.fertnstert.2024.11.011. Epub 2024 Nov 14. Fertil Steril. 2025. PMID: 39547644
Cited by
-
The Future of Cryopreservation in Assisted Reproductive Technologies.Front Endocrinol (Lausanne). 2020 Feb 20;11:67. doi: 10.3389/fendo.2020.00067. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32153506 Free PMC article. Review.
-
Prediction, assessment, and management of suboptimal GnRH agonist trigger: a systematic review.J Assist Reprod Genet. 2022 Feb;39(2):291-303. doi: 10.1007/s10815-021-02359-y. Epub 2022 Mar 19. J Assist Reprod Genet. 2022. PMID: 35306603 Free PMC article.
-
Influence of combined oral contraceptive pill before PPOS protocol on egg donors and recipients' outcomes: an international multicenter retrospective study.J Assist Reprod Genet. 2025 Jul;42(7):2341-2350. doi: 10.1007/s10815-025-03519-0. Epub 2025 May 29. J Assist Reprod Genet. 2025. PMID: 40439989
-
Progestin-primed ovarian stimulation protocol with or without clomiphene citrate for poor ovarian responders: a retrospective cohort study.BMC Womens Health. 2022 Dec 17;22(1):527. doi: 10.1186/s12905-022-02126-w. BMC Womens Health. 2022. PMID: 36528555 Free PMC article.
-
Clinical efficacy of dual trigger with human chorionic gonadotropin and a gonadotropin-releasing hormone agonist for women undergoing fertility preservation.Reprod Med Biol. 2022 Feb 4;21(1):e12440. doi: 10.1002/rmb2.12440. eCollection 2022 Jan-Dec. Reprod Med Biol. 2022. PMID: 35386366 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical